MSLPQ (MusclePharm) 12-1 Month Momentum % : -70.00% (As of Nov. 07, 2024)

View and export this data going back to 2008. Start your Free Trial

What is MusclePharm 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-11-07), MusclePharm's 12-1 Month Momentum % is -70.00%.

The industry rank for MusclePharm's 12-1 Month Momentum % or its related term are showing as below:

MSLPQ's 12-1 Month Momentum % is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 1.99 vs MSLPQ: -70.00

Competitive Comparison of MusclePharm's 12-1 Month Momentum %

For the Packaged Foods subindustry, MusclePharm's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MusclePharm's 12-1 Month Momentum % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, MusclePharm's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where MusclePharm's 12-1 Month Momentum % falls into.

MusclePharm (OTCPK:MSLPQ) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MusclePharm (OTCPK:MSLPQ) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

MusclePharm 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of MusclePharm's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

MusclePharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » MusclePharm Corp (OTCPK:MSLPQ) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7380 South Eastern Avenue, Suite 124-287, Las Vegas, NV, USA, 89123

Website

https://www.musclepharm.com

MusclePharm Corporation is a performance lifestyle company. It develops, manufactures, markets, and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets, and gels. Geographically, the firm has its business presence across the region of the US and in the international market of which the US accounts for the majority of revenue. MusclePharm's Hybrid series products include Assault, Combat Protein Powder, BCAA 3:1:2, CLA Core, Fish Oil, Combat Crunch Protein Bars, glutamine, carnitine, Combat Crunch, Protein Crisp, Organic Protein, and Protein Cookie. The group sells its products to various fitness enthusiasts, such as professional, combat sports, weight training, bodybuilding, running, and various team and individual sports, and others.

Executives

Eric Chin	officer: Chief Accounting Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Paul W Karr	director	BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154
Sabina Rizvi	officer: President & CFO	6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118
Michael David Heller	director	4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302
Wynnefield Partners Small Cap Value Lp I	10 percent owner	450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Donald Feagan	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Amerop Holdings, Inc.	10 percent owner	1800 BROADWAY, SUITE 100, BOULDER CO 80302
White Winston Select Asset Fund Series Fund Mp-18, Llc	10 percent owner	C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110
Robert P Mahoney	10 percent owner	4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611
White Winston Select Asset Funds, Llc	10 percent owner	265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110
Todd M. Enright	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Mark Blundell	10 percent owner	8 MACDONALD AVE, ARMOUK NY 10504
John J Desmond	director	10 GLEN HEAD ROAD, GLEN HEAD NY 11545
Wynnefield Small Cap Value Offshore Fund Ltd	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123
Wynnefield Capital Inc	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123